Table 2.

Percentage of patients with presence of hemi-methylation in CRABP1 and CRABP2 gene promoters.

	CRABP1 HEMI-METHYLATION		CRABP2 HEMI-METHYLATION
	% (n)	rho (P)§	% (n)	rho (P)§
NIL	18.2 (4/22)*	0.290 (<0.001)	4.6 (1/22)	0.145 (0.069)
LSIL	16.7 (7/42)*		4.8 (2/42)
HSIL	26.1 (18/69)*		4.6 (3/69)*
CC	64.0 (16/25)		20.0 (5/25)

Notes:

^§Statistically significant Spearman’s correlation coefficient (rho) (P < 0.05).

^*Analysis of proportions showing significant differences between CC and the other groups (P < 0.05).